Sources | Names Used |
---|---|
CTRPv2 | Repligen 136 |
PharmacoGx | Repligen 136 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LIG3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | MYO15B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | TAF11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | MKS1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SLC20A1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | CDK17 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ZNF529 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | ATP6V1G2-DDX39B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | IFITM2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ANTXR1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |